1-1 of 1
Keywords: Adecatumumab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy

Available to Purchase
Subject Area:
Further Areas
Norbert Marschner, Dominik Rüttinger, Gerhard Zugmaier, Gyula Nemere, Jan Lehmann, Peter Obrist, Patrick A. Baeuerle, Andreas Wolf, Margit Schmidt, Per-Anders Abrahamsson, Carsten Reinhardt, Axel Heidenreich
Journal: Urologia Internationalis
Urol Int (2010) 85 (4): 386–395.
https://doi.org/10.1159/000318055
Published Online: 02 July 2010
... prostatectomy are indicative of recurrent prostate cancer. This double-blind, placebo-controlled phase II study evaluated the anti-tumour activity of the anti-epithelial cell adhesion molecule (EpCAM) antibody adecatumumab in delaying biochemical disease progression. Patients and Methods: Prostate cancer...
View article titled, Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
Open the PDF for Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy in another window